University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES) : PathIES

dc.contributor.authorCheang, M C U
dc.contributor.authorBliss, J M
dc.contributor.authorViale, G
dc.contributor.authorSpeirs, V
dc.contributor.authorPalmieri, C
dc.contributor.authorShaaban, A
dc.contributor.authorLønning, P E
dc.contributor.authorMorden, J
dc.contributor.authorPorta, N
dc.contributor.authorJassem, J
dc.contributor.authorvan De Velde, C J
dc.contributor.authorRasmussen, B B
dc.contributor.authorVerhoeven, D
dc.contributor.authorBartlett, J M S
dc.contributor.authorCoombes, R C
dc.contributor.authorPathIES Sub-Committee
dc.date.accessioned2018-07-30T14:39:08Z
dc.date.available2018-07-30T14:39:08Z
dc.date.issued2018-02
dc.descriptionThis work was supported by Cancer Research UK (C37/A8434) and Pfzer (GA9001DP). Cancer Research UK also providedprogramme grants to the Institute of Cancer Research Clinical Trials and Statistics Unit and the Division of Cancer at Imperial College London. This study was supported by Imperial Experimental Cancer Medicine Centre, Imperial Biomedical Research Centre and Imperial Cancer Research UK Centre. MCUC is supported by the Cancer Research UK Core grant (Grant Number C1491/A15955).en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent877955
dc.identifier129546005
dc.identifiere749d8cb-6700-4760-ad9d-32dc2101a369
dc.identifier29177605
dc.identifier85035116479
dc.identifier.citationCheang, M C U, Bliss, J M, Viale, G, Speirs, V, Palmieri, C, Shaaban, A, Lønning, P E, Morden, J, Porta, N, Jassem, J, van De Velde, C J, Rasmussen, B B, Verhoeven, D, Bartlett, J M S, Coombes, R C & PathIES Sub-Committee 2018, 'Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES) : PathIES', Breast Cancer Research and Treatment, vol. 168, no. 1, pp. 169-178. https://doi.org/10.1007/s10549-017-4543-7en
dc.identifier.doi10.1007/s10549-017-4543-7
dc.identifier.iss1en
dc.identifier.issn0167-6806
dc.identifier.otherPubMedCentral: PMC5847042
dc.identifier.otherORCID: /0000-0002-0602-4666/work/72631318
dc.identifier.urihttp://hdl.handle.net/2164/10831
dc.identifier.vol168en
dc.language.isoeng
dc.relation.ispartofBreast Cancer Research and Treatmenten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectJournal Articleen
dc.subjectbreast canceren
dc.subjectaromataseen
dc.subjectprognosisen
dc.subjectR Medicineen
dc.subjectCancer Research UKen
dc.subjectC37/A8434en
dc.subjectC1491/A15955en
dc.subject.lccRen
dc.titleEvaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES) : PathIESen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cheang2018_Article_EvaluationOfApplyingIHC4AsAPro.pdf
Size:
857.38 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: